Trending...
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
O'Donnell Brings Wealth of Antitrust, Complex Commercial Litigation Expertise in Pharma Industry
PHILADELPHIA, Jan. 24, 2023 /PRNewswire/ -- Melissa Hatch O'Donnell, a talented health care attorney with significant experience in antitrust law, False Claims Act, and other complex commercial litigation, has rejoined Troutman Pepper as a partner in the firm's Health Sciences Litigation Practice Group. O'Donnell returns to the firm's Philadelphia office after spending nearly four years in-house with Cigna, where she provided litigation and regulatory counsel, and focused on pharmacy benefit managers' relationships with pharmaceutical manufacturers, health plans, and pharmacies.
"We are delighted to welcome Melissa back to the firm," said Sean Fahey, chair of the firm's Health Sciences Litigation Practice Group. "As we see demand for top-flight health care-focused litigators continue to grow, her addition deepens our bench strength for clients, particularly in the critical areas of antitrust law and complex commercial litigation."
More on The PennZone
O'Donnell brings extensive experience handling class action and large multidistrict litigations, as well as commercial, antitrust, unfair trade practice, and health care litigation. Drawing from in-house experience at a multinational, publicly traded health solutions company, O'Donnell advises clients in the health care and life sciences sectors in matters involving civil and criminal antitrust, competition, and other regulatory risks.
"I am thrilled to return to Troutman Pepper and private practice," O'Donnell said. "My time in-house has given me critical insight into what clients value, and I look forward to applying that experience to counsel clients through their toughest antitrust, competition, and regulatory matters."
After earning her B.A. from Penn State University, O'Donnell earned both her J.D. and her M.A. in Bioethics from the University of Pennsylvania. Prior to transitioning in-house, O'Donnell began her legal career with Troutman Pepper in 2010.
Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients with complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
More on The PennZone
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm's litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients' most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
SOURCE Troutman Pepper Hamilton Sanders LLP
PHILADELPHIA, Jan. 24, 2023 /PRNewswire/ -- Melissa Hatch O'Donnell, a talented health care attorney with significant experience in antitrust law, False Claims Act, and other complex commercial litigation, has rejoined Troutman Pepper as a partner in the firm's Health Sciences Litigation Practice Group. O'Donnell returns to the firm's Philadelphia office after spending nearly four years in-house with Cigna, where she provided litigation and regulatory counsel, and focused on pharmacy benefit managers' relationships with pharmaceutical manufacturers, health plans, and pharmacies.
"We are delighted to welcome Melissa back to the firm," said Sean Fahey, chair of the firm's Health Sciences Litigation Practice Group. "As we see demand for top-flight health care-focused litigators continue to grow, her addition deepens our bench strength for clients, particularly in the critical areas of antitrust law and complex commercial litigation."
More on The PennZone
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
- Can Government Operate Better Through Innovation?
O'Donnell brings extensive experience handling class action and large multidistrict litigations, as well as commercial, antitrust, unfair trade practice, and health care litigation. Drawing from in-house experience at a multinational, publicly traded health solutions company, O'Donnell advises clients in the health care and life sciences sectors in matters involving civil and criminal antitrust, competition, and other regulatory risks.
"I am thrilled to return to Troutman Pepper and private practice," O'Donnell said. "My time in-house has given me critical insight into what clients value, and I look forward to applying that experience to counsel clients through their toughest antitrust, competition, and regulatory matters."
After earning her B.A. from Penn State University, O'Donnell earned both her J.D. and her M.A. in Bioethics from the University of Pennsylvania. Prior to transitioning in-house, O'Donnell began her legal career with Troutman Pepper in 2010.
Troutman Pepper's leading life sciences and health care practice counsels clients at all stages of the health care continuum – from drug development to clinical care – from emerging biotech to global pharma. The firm takes an integrated, interdisciplinary approach to counsel clients with complex, evolving needs, providing critical support including intellectual property prosecution and litigation, corporate finance and governance, privacy and cybersecurity, litigation, regulatory, and enforcement.
More on The PennZone
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Her Song Lives On: Remembering Mrs. Darlene Davis Porter
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Pittsburgh Creators Launch Clever New Children's Book, "The Sock Sleuth!"
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm's litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients' most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.
SOURCE Troutman Pepper Hamilton Sanders LLP
0 Comments
Latest on The PennZone
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- SMACK Fight Week Takes Over Philadelphia
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- Spearmint Publishes Full Design of Its Mining Pool Before Building It, Including Legal Drafts
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Brewtay Coffee Introduces Specialty Instant Line Designed for High-Velocity Commuters and Travelers
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Ten Ten Ten Awards Provisional Certification to Cara AI for Home-Based Health Assessments
- IDI Consulting Partners with the American Heart Association to Advance Heart Health Awareness
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Diversity Committee
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
